We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $33.1B
1-Year Est. Return 11.16%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+11.16%
3 Year Est. Return
+63.39%
5 Year Est. Return
+85.45%
10 Year Est. Return
+744.36%
AUM
$40.6B
AUM Growth
+$145M
Cap. Flow
+$263M
Cap. Flow %
0.65%
Top 10 Hldgs %
34.5%
Holding
414
New
37
Increased
147
Reduced
146
Closed
20

Top Buys

Rank Stock Value
1
TRIP icon
TripAdvisor
TRIP
+$214M
2
BBIO icon
BridgeBio Pharma
BBIO
+$64.6M
3
BABA icon
Alibaba
BABA
+$59.9M
4
EPAM icon
EPAM Systems
EPAM
+$57.3M
5
SFIX
Stitch Fix
SFIX
+$56.5M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$439M
2
IDXX icon
Idexx Laboratories
IDXX
+$98.8M
3
PACB icon
Pacific Biosciences
PACB
+$52.9M
4
DASH icon
DoorDash
DASH
+$49.8M
5
BKNG icon
Booking.com
BKNG
+$49.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.86%
2 Technology 20.53%
3 Healthcare 14.72%
4 Financials 13.63%
5 Real Estate 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAB icon
301
Genmab
GMAB
$17.5B
$7.86M 0.02%
239,467
+94,193
+65% +$3.54M
BEAM icon
302
Beam Therapeutics
BEAM
$2.68B
$7.84M 0.02%
+98,017
New +$9.32M
CMRC
303
Commerce.com Inc Series 1
CMRC
$272M
$7.75M 0.02%
134,036
POOL icon
304
Pool Corp
POOL
$7.05B
$7.71M 0.02%
22,337
-5,480
-20% -$1.91M
PRKS icon
305
United Parks & Resorts
PRKS
$2.19B
$7.4M 0.02%
148,960
-155,442
-51% -$6.16M
QLYS icon
306
Qualys
QLYS
$4.76B
$7.33M 0.02%
70,000
-80,000
-53% -$8.95M
AZN icon
307
AstraZeneca
AZN
$269B
$7.18M 0.02%
72,254
-102,163
-59% -$10.3M
A icon
308
Agilent Technologies
A
$39.6B
$7.13M 0.02%
56,065
+237
+0.4% +$29.3K
FWONA icon
309
Liberty Media Series A
FWONA
$23.4B
$7.07M 0.02%
193,227
SONY icon
310
Sony
SONY
$137B
$6.87M 0.02%
324,015
YAC
311
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$6.05M 0.01%
590,500
RHI icon
312
Robert Half
RHI
$4.11B
$5.94M 0.01%
76,128
MANH icon
313
Manhattan Associates
MANH
$12.1B
$5.81M 0.01%
49,500
-2,514
-5% -$304K
MRNA icon
314
Moderna
MRNA
$21.6B
$5.79M 0.01%
44,182
+40,382
+1,063% +$5.85M
TMO icon
315
Thermo Fisher Scientific
TMO
$214B
$5.78M 0.01%
12,659
+5,700
+82% +$2.72M
ACIC
316
DELISTED
Atlas Crest Investment Corp.
ACIC
$5.38M 0.01%
502,000
WORK
317
DELISTED
Slack Technologies, Inc.
WORK
$5.37M 0.01%
132,140
-773,608
-85% -$32.4M
TXMD icon
318
TherapeuticsMD
TXMD
$23.8M
$5.13M 0.01%
76,630
ABT icon
319
Abbott
ABT
$188B
$4.98M 0.01%
41,578
+18,950
+84% +$2.25M
AGC
320
DELISTED
Altimeter Growth Corp
AGC
$4.86M 0.01%
397,909
SPCE icon
321
Virgin Galactic
SPCE
$315M
$4.59M 0.01%
7,500
APLT
322
DELISTED
Applied Therapeutics
APLT
$4.46M 0.01%
237,800
+110,800
+87% +$2.39M
HUM icon
323
Humana
HUM
$43.9B
$4.42M 0.01%
10,550
+1,600
+18% +$639K
TSEM icon
324
Tower Semiconductor
TSEM
$21.2B
$4.28M 0.01%
152,785
-36,963
-19% -$1.09M
VLD
325
DELISTED
Velo3D, Inc.
VLD
$4.1M 0.01%
+11,429
New +$4.35M

Similar funds

BAMCO Inc's Q1 2021 Portfolio in Review

As of Q1 2021, BAMCO Inc held 414 positions worth $40.6B, up 0.36% from $40.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

BAMCO Inc's Q1 2021 filing shows 37 new, 147 increased, 146 reduced and 20 closed positions. Its largest new stake was TripAdvisor: 4,978,359 shares worth $268M. The largest sale was Tesla, an estimated $439M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • BAMCO Inc's largest Q1 2021 buy was TripAdvisor: 4,978,359 shares worth $268M.
  • BAMCO Inc added most to BridgeBio Pharma in Q1 2021, an estimated $64.6M increase.
  • BAMCO Inc's biggest Q1 2021 reduction was Tesla, cutting an estimated $439M.
  • BAMCO Inc fully exited DoorDash in Q1 2021, selling an estimated $49.8M.
  • BAMCO Inc's ten largest holdings make up 34% of its $40.6B portfolio in Q1 2021.
  • BAMCO Inc opened 37 new positions and closed 20 in Q1 2021.
  • BAMCO Inc's portfolio value rose 0.36% quarter-over-quarter to $40.6B.

Based on BAMCO Inc's 13F filing for Q1 2021, filed 19 May 2021.